Detalles de la búsqueda
1.
Distinct maternal metabolites are associated with obesity and glucose-insulin axis in the first trimester of pregnancy.
Int J Obes (Lond)
; 47(7): 529-537, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37029207
2.
First-line therapy with bendamustine/prednisone/bortezomib-A GMMG trial for non-transplant eligible symptomatic multiple myeloma patients.
Eur J Haematol
; 105(2): 116-125, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32155662
3.
Marker chromosomes can arise from chromothripsis and predict adverse prognosis in acute myeloid leukemia.
Blood
; 129(10): 1333-1342, 2017 03 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28119329
4.
Rationale and design of the German-speaking myeloma multicenter group (GMMG) trial HD6: a randomized phase III trial on the effect of elotuzumab in VRD induction/consolidation and lenalidomide maintenance in patients with newly diagnosed myeloma.
BMC Cancer
; 19(1): 504, 2019 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-31138244
5.
Prognostic impact of cytogenetic aberrations in AL amyloidosis patients after high-dose melphalan: a long-term follow-up study.
Blood
; 128(4): 594-602, 2016 07 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-27257181
6.
In Vitro, Ex Vivo, and In Vivo Activities of Diamidines against Trypanosoma congolense and Trypanosoma vivax.
Antimicrob Agents Chemother
; 61(5)2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28193658
7.
Heterogeneous treatment effects in stratified clinical trials with time-to-event endpoints.
Biom J
; 59(3): 511-530, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28263395
8.
Increased microcirculation detected by dynamic contrast-enhanced magnetic resonance imaging is of prognostic significance in asymptomatic myeloma.
Br J Haematol
; 174(1): 127-35, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-26991959
9.
Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE: a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transplantation and lenalidomide maintenance in patients with relapsed multiple myeloma.
BMC Cancer
; 16: 290, 2016 Apr 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-27114074
10.
Prognostic significance of increased bone marrow microcirculation in newly diagnosed multiple myeloma: results of a prospective DCE-MRI study.
Eur Radiol
; 26(5): 1404-11, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26215436
11.
Model-based evaluation of pulmonary pharmacokinetics in asthmatic and COPD patients after oral olodaterol inhalation.
Br J Clin Pharmacol
; 82(3): 739-53, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27145733
12.
Investigating pulmonary and systemic pharmacokinetics of inhaled olodaterol in healthy volunteers using a population pharmacokinetic approach.
Br J Clin Pharmacol
; 81(3): 538-52, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26348533
13.
Subcutaneous versus intravenous bortezomib in two different induction therapies for newly diagnosed multiple myeloma: an interim analysis from the prospective GMMG-MM5 trial.
Haematologica
; 100(7): 964-9, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25840597
14.
Blinded versus unblinded covariate selection in confirmatory survival trials.
J Biopharm Stat
; 24(2): 398-414, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24605976
15.
Bioaccessibility and Digestibility of Proteins in Plant-Based Drinks and Cow's Milk: Antioxidant Potential of the Bioaccessible Fraction.
J Agric Food Chem
; 72(4): 2300-2308, 2024 Jan 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38235666
16.
Elotuzumab, lenalidomide, bortezomib, dexamethasone, and autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GMMG-HD6): results from a randomised, phase 3 trial.
Lancet Haematol
; 11(2): e101-e113, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38302221
17.
Peripheral neuropathy associated with subcutaneous or intravenous bortezomib in patients with newly diagnosed myeloma treated within the GMMG MM5 phase III trial.
Haematologica
; 101(12): e485-e487, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27540135
18.
Neonatal antibiotic exposure impairs child growth during the first six years of life by perturbing intestinal microbial colonization.
Nat Commun
; 12(1): 443, 2021 01 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33500411
19.
Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age.
Leukemia
; 35(3): 809-822, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32684633
20.
Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma.
Blood Cancer J
; 11(1): 1, 2021 01 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33414374